TY  - JOUR
AU  - García Cárceles, Javier
AU  - Brea, José
AU  - Vázquez Villa, María Del Henar
AU  - Ladron de Guevara-Miranda, David
AU  - Cincilla, Giovanni
AU  - Sánchez Martínez, Melchor
AU  - Sánchez Merino, Anabel
AU  - Algar Lizana, Sergio
AU  - Teresa de los Frailes, María
AU  - Roberts, Richard S.
AU  - Ballesteros, Juan A.
AU  - Rodríguez de Fonseca, Fernando
AU  - Benhamú Salama, Bellinda
AU  - Loza, María I.
AU  - López Rodríguez, María Luz
PY  - 2022
DO  - 10.1021/acs.jmedchem.2c00949
SN  - 0022-2623
UR  - https://hdl.handle.net/20.500.14352/71989
T2  - Journal of Medicinal Chemistry
AB  - Tolerance development caused by dopamine replacement with L-DOPA and therapeutic drawbacks upon activation of dopaminergic receptors with orthosteric agonists reveal a significant unmet need for safe and effective treatment of Parkinson’s disease. In...
LA  - eng
PB  - ACS
TI  - 2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1 Receptor for Parkinson’s Disease
TY  - journal article
ER  -